Ascendis Health Overview

  • Founded
  • 2008
Founded
  • Status
  • Public
  • Stock Symbol
  • ASC
Stock Symbol
  • Investments
  • 20
  • Share Price
  • $0.05
  • (As of Friday Closing)

Ascendis Health General Information

Description

Ascendis Health Limited is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. Ascendis Health has four segments: Phyto-Vet, Consumer Brands, Pharma-Med, and International. The Phyto-Vet segment supplies health and care products to the plants and animal market. The Consumer brands segment sells vitamins and minerals, ayurvedic products, herbal products, weight management products, and sports nutritional supplements. The Pharma-Med segment provides prescription medicine and medical devices. The International segment sells the aforementioned products abroad. The company earns the majority of its revenue in South Africa.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Stock Exchange
JSE
Primary Office
  • PostNet, Suite 252
  • Private Bag X21
  • Johannesburg, Gauteng 2191
  • South Africa
+27 011 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ascendis Health Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.05 $0.05 $0.02 - $0.13 $22.7M 478M 806K -$0.13

Ascendis Health Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 410,929 410,929 540,439 773,956
Revenue 417,185 417,185 390,540 391,499
EBITDA 14,243 14,243 (70,862) 56,171
Net Income (63,815) (63,815) (331,507) 20,006
Total Assets 707,863 707,863 795,699 1,149,634
Total Debt 417,900 417,900 412,427 407,175
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ascendis Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ascendis Health‘s full profile, request access.

Request a free trial

Ascendis Health Executive Team (6)

Name Title Board Seat Contact Info
Mark Sardi Chief Executive Officer
Kieron Futter Chief Financial Officer
Andy Sims Company Secretary & Chief Risk Officer
You’re viewing 3 of 6 executive team members. Get the full list »

Ascendis Health Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ascendis Health‘s full profile, request access.

Request a free trial

Ascendis Health Investments & Acquisitions (20)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000 29-Nov-2017 000000000000000000 000.00 Medical Supplies
000 0000 000000 02-Jun-2017 000000000000000000 000.00 Pharmaceuticals 0000000 0000000 00.0
000 0000000 000000 01-Jun-2017 000000000000000000 000.00 Pharmaceuticals 0000000 0000000 00.0
00000 (00000 00000 01-Apr-2017 000000000000000000 000.00 Pharmaceuticals
Scitec Nutrition 26-Aug-2016 Merger/Acquisition 00000 Beverages 0000000 0000000 00.0
You’re viewing 5 of 20 investments and acquisitions. Get the full list »

Ascendis Health Subsidiaries (9)

Company Name Industry Location Founded
SOLAL Technologies Food Products Johannesburg, South Africa 2009
000 0000 000000 Pharmaceuticals Bucuresti, Romania 0000
0000000000 000000 Other Pharmaceuticals and Biotechnology Umhlanga Rocks, South Africa 0000
00000000000 0000 0 Medical Supplies Johannesburg, South Africa 0000
00000 0000 0000000 Personal Products Rivonia, South Africa 0000
You’re viewing 5 of 9 subsidiaries. Get the full list »

Ascendis Health Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 000000000 26-Aug-2016 000000000000000000 00000 Completed
  • 00000000 000000
00000000 01-Feb-2016 000000000000000000 000.00 Completed
  • 00000000 000000
00000000 0000 & 00 11-Jul-2013 0000000000 000.00 Completed
  • 2 buyers
Efekto 01-Sep-2011 Buyout/LBO Completed
  • 4 buyers
To view Ascendis Health’s complete exits history, request access »